OMX Copenhagen 20
1.615,01
PKT
-1,74
PKT
-0,11
%
Werbung
Analysen zu OMX Copenhagen 20-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.10.20 | Novo Nordisk kaufen | Bernstein Research | |
| 30.10.20 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.10.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 30.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 30.10.20 | Novo Nordisk Neutral | UBS AG | |
| 30.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.10.20 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 16.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.10.20 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 15.10.20 | A.P. Moeller - Maersk A-S (B) buy | Kepler Cheuvreux | |
| 14.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 14.10.20 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 13.10.20 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 13.10.20 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 12.10.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 09.10.20 | Novo Nordisk Neutral | UBS AG | |
| 09.10.20 | Novo Nordisk Verkaufen | DZ BANK | |
| 09.10.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.10.20 | A.P. Moeller - Maersk A-S (B) kaufen | Deutsche Bank AG | |
| 29.09.20 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.09.20 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 29.09.20 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 25.09.20 | Novo Nordisk Neutral | UBS AG | |
| 22.09.20 | A.P. Moeller - Maersk A-S (B) overweight | JP Morgan Chase & Co. | |
| 15.09.20 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 02.09.20 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 21.08.20 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 21.08.20 | A.P. Moeller - Maersk A-S (B) Hold | Jefferies & Company Inc. | |
| 21.08.20 | A.P. Moeller - Maersk A-S (B) Neutral | JP Morgan Chase & Co. | |
| 20.08.20 | A.P. Moeller - Maersk A-S (B) buy | Deutsche Bank AG | |
| 20.08.20 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 19.08.20 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 18.08.20 | Novo Nordisk Neutral | UBS AG | |
| 18.08.20 | A.P. Moeller - Maersk A-S (B) buy | Kepler Cheuvreux | |
| 14.08.20 | Novo Nordisk Hold | Kepler Cheuvreux | |
| 11.08.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 07.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. |